One ominous case of focal atrial tachycardia in pregnancy, two victims and a successful outcome: a case report
International Journal of Arrhythmia volume 23, Article number: 28 (2022)
Pregnancy is associated with both new-onset and exacerbation of pre-existing arrhythmias, particularly supraventricular tachycardia, with increased maternal and fetal risks and with added concerns on the safety of the available drug therapy and catheter ablation techniques.
These are often withheld, with worse outcomes, and lead to challenging decisions in the approach to pregnant women with refractory supraventricular arrhythmias.
We present a case of a 28-year-old 37-weeks pregnant woman with symptomatic, almost incessant, atrial tachycardia causing tachycardia-induced cardiomyopathy, refractory to medical therapy, that evolved in acute cardiac failure and needed emergency cesarian delivery. The patient was afterward submitted to catheter ablation therapy, with an electrical isolation of the ectopic foci on the lower left pulmonary vein with radiofrequency and total suppression of the arrhythmia. The patient and infant were discharged clinically well and during follow-up the patient was asymptomatic, without recurrence of tachycardia and with complete recovery of left ventricle function.
This case highlights the challenges in the treatment of this special population with a stepwise medical approach that proved ineffective and clinical deterioration requiring termination of pregnancy and catheter ablation in the postpartum period, with a successful maternal and fetal outcome.
Arrhythmias are a common cardiovascular complication in pregnancy and have been increasing in recent years . Women with pre-existing arrhythmias are at high risk of recurrence or exacerbation during pregnancy, particularly in the latter part of the second trimester, third trimester and peripartum period . This may be due to a variety of factors such as: increased plasma catecholamine concentrations; increased heart rate; temporary cardiac remodeling associated with progesterone, estrogen and relaxin; and an increased ventricular end-diastolic volume caused by intravascular volume expansion [2,3,4]. The treatment of such arrhythmias poses a challenge, given the potential teratogenic effect of some of the drugs commonly used and of the radiation implicated in catheter ablation .
A 28-year-old patient, 37-weeks pregnant, with no relevant priors or regular medication, was consulted by her gynecologist due to a long-lasting history of palpitations and pre-syncope aggravated since the twentieth week of pregnancy.
A 12-lead electrocardiogram and a 24-h Holter monitoring were requested that demonstrated repetitive, almost incessant, narrow QRS complex tachycardia alternating with rare sinus beats, suggestive of atrial tachycardia (Figs. 1 and 2). The average heart rate was 155 beats per minute (bpm), maximum of 234 bpm and a minimum of 84 bpm. A cardiology consultation was then requested, and the patient was immediately admitted for initiation of antiarrhythmic therapy under close monitoring.
At admission the patient was hemodynamically stable with an unremarkable physical examination, except for a rapid and irregular rhythm. A transthoracic echocardiogram (Additional File 1: Video S1) demonstrated a dilated left ventricle with diffuse hypokinesis and moderately compromised ejection fraction (35% by Simpson Biplane) and a diagnosis of tachycardia-induced cardiomyopathy was assumed.
Administration of adenosine with complete atrioventricular block demonstrated monomorphic P waves and resumption of clinical arrhythmia. The patient was started on propranolol in uptitrating doses and flecainide which were ineffective. Digoxin was then administered with some reduction in the average heart rate while maintaining frequent symptomatic episodes of atrial tachycardia.
The patient evolved in acute congestive cardiac failure at third day of admission and, after multidisciplinary meetings, an emergency cesarean delivery was decided on and performed. Perioperative hemodynamically instability occurred with transient need of vasopressor therapy. The patient was admitted in an intensive care unit achieving clinical stability at 24 h. The newborn was admitted in a neonatal intensive care unit as a precaution.
Given the poor response to pharmacological treatment the patient was submitted to an electrophysiological study. The study confirmed a focal atrial tachycardia (Fig. 3) and, using a 3D mapping system (CARTO ©3D Mapping system), identified the earliest local activation at the lower left pulmonary vein (Fig. 4 and Additional File 2: Video S2). An electrical isolation of the vein with radiofrequency catheter ablation was performed with total suppression of the ectopic foci (Fig. 5). There was no recurrence, even after infusion of isoprenaline.
Upon clinical improvement, the patient was discharged, asymptomatic, and without recurrence of the arrhythmia. The newborn evolved clinically well, without sequelae.
In the follow-up at 4 months the patient was asymptomatic, without drug therapy, with normal resumption of everyday activity. There was no recurrence of arrhythmia or supraventricular extrasystoles on a 24 h Holter monitoring and the transthoracic echocardiogram (Additional File 3: Video S3) showed a non-dilated left ventricle, without regional wall motion abnormalities, and a complete recovery of left ventricular function (64% by Simpson Biplane).
Paroxysmal supraventricular tachycardia has been previously considered the most frequent sustained arrhythmia in pregnancy. However, atrial fibrillation and ventricular tachycardia have had an increasing frequency, probably due to increasing maternal age and cardiovascular risk factors [3, 4]. Hospitalizations during pregnancy for arrhythmias are associated with an increased risk of both maternal and fetal complications, including maternal mortality .
In the treatment of atrial arrhythmias one should consider that although some drugs are deemed safe, most data on the safety of medication use during pregnancy relies on observational studies and expert opinion .
Some beta-blockers, like propranolol, and digoxin have extensive data in its safety and were therefore used in our patient but with poor clinical response. Flecainide is considered moderately safe in pregnancy, while other drugs like propafenone have mixed data [3, 4], and thus opted for although once again with no satisfying result. Amiodarone was not used as it is contraindicated in pregnancy .
Catheter ablation has been successfully performed during pregnancy in experienced centers using either minimal fluoroscopy or electroanatomic mapping systems and intracardiac ultrasound (“zero-fluoroscopic ablation”) for drug-refractory and poorly tolerated arrhythmias . However, given the scarce data and the potential fetal and maternal procedural risk, deferring ablation until the postpartum period is preferred whenever possible . After close coordination with the Gynecology department, and given an early term pregnancy with adequate fetal development, an emergency cesarian delivery was opted for and a catheter ablation was successfully performed afterward, with good clinical outcome.
This case highlights a malignant course of focal atrial tachycardia, aggravated by pregnancy and unresponsive to medical therapy, with a successful catheter ablation therapy and clinical response, demonstrating the paramount importance of a multidisciplinary and stepwise approach to a complex situation.
Availability of data and materials
Vaidya VR, Arora S, Patel N, Badheka AO, Patel N, Agnihotri K, Billimoria Z, Turakhia MP, Friedman PA, Madhavan M, Kapa S, Noseworthy PA, Cha YM, Gersh B, Asirvatham SJ, Deshmukh AJ. Burden of arrhythmia in pregnancy. Circulation. 2017;135(6):619–21. https://doi.org/10.1161/CIRCULATIONAHA.116.026681 (PMID: 28154000).
Williams DS, Mikhova K, Sodhi S. Arrhythmias and pregnancy: management of preexisting and new-onset maternal arrhythmias. Cardiol Clin. 2021;39(1):67–75. https://doi.org/10.1016/j.ccl.2020.09.013 (PMID: 33222815).
Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457–76. https://doi.org/10.1016/j.jacc.2018.10.075 (PMID: 30704579).
Tamirisa KP, Elkayam U, Briller JE, Mason PK, Pillarisetti J, Merchant FM, Patel H, Lakkireddy DR, Russo AM, Volgman AS, Vaseghi M. Arrhythmias in pregnancy. JACC Clin Electrophysiol. 2022;8(1):120–35. https://doi.org/10.1016/j.jacep.2021.10.004 (Epub 2021 Dec 22 PMID: 35057977).
The author wishes to acknowledge the contribution of João Simões, Khrystyna Budzak and Carlos Alvarenga for acquisition and processing of the images collected.
The authors declare there is no funding source to disclose.
Ethical approval and consent to participate
Consent for publication
All data generated is anonymized.
The authors declare that they have no competing interests to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations'' (in PDF at the end of the article below the references; in XML as a back matter article note).
. A transthoracic echocardiogram demonstrating a dilated left ventricle with diffuse hypokinesis and moderately compromised ejection fraction (35% by Simpson Biplane).
Additional file 2: Video S2. The electrophysiological study performed in focal atrial tachycardia identified the region of earliest local activation in the lower left pulmonary vein (CARTO ©3D Mapping system).
Additional file 3: Video S3. A transthoracic echocardiogram demonstrating a non-dilated left ventricle, without regional wall motion abnormalities, and a normal left ventricular ejection fraction (64% by Simpson Biplane).
About this article
Cite this article
Santos, J.G., Briosa, A., Sebaiti, D. et al. One ominous case of focal atrial tachycardia in pregnancy, two victims and a successful outcome: a case report. Int J Arrhythm 23, 28 (2022). https://doi.org/10.1186/s42444-022-00079-7